Altogether, our data highlight the proline vulnerability of HSD-enhanced Ras/Src-tumours and uncover modulation of amino acid transporter repertoire as a strategy to meet the nutrient requirements of tumourigenesis. The gene discussed is SRC; the disease is neoplasm.